← All trials
NCT01427738
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2011
- Primary completion
- Sep 1, 2012
- Completion date
- Jan 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 221
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- AIDS Clinical Trials GroupLead sponsor
- Case Western Reserve UniversityOverall official - principal investigator
- Eastman Dental HospitalOverall official - principal investigator
- National AIDS Research Institute, PuneOverall official - principal investigator
- Parirenyatwa HospitalOverall official - principal investigator
- National Institute of Allergy and Infectious Diseases (NIAID)Collaborator
- Joint Clinical Research Centre, Kampala, UgandaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.